Cancer Constipation

Cancer Constipation

The ONS Guidelines for management of opioid-induced and nonopioid-related cancer constipation have been developed by a panel of oncology healthcare providers after rigorous systematic review of high-quality randomized clinical trials designed to establish the evidence-based efficacy of prevention of...

Full description

Saved in:
Bibliographic Details
Published in:Clinical journal of oncology nursing Vol. 24; no. 6; pp. 685 - 688
Main Authors: LeFebvre, Kristine B, Rogers, Barbara, Wolies, Brenda
Format: Journal Article
Language:English
Published: Pittsburgh Oncology Nursing Society 01-12-2020
Subjects:
Acupuncture
Adults
Cancer therapies
Caregivers
Chronic illnesses
Clinical trials
Constipation
Cost estimates
Dietitians
Disease prevention
Laxatives
Lifestyles
Narcotics
Nurses
Nursing care
Oncology
Patients
Polyethylene glycol
Systematic review
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The ONS Guidelines for management of opioid-induced and nonopioid-related cancer constipation have been developed by a panel of oncology healthcare providers after rigorous systematic review of high-quality randomized clinical trials designed to establish the evidence-based efficacy of prevention of and interventions to manage constipation in adults with cancer. For adults experiencing opioid-induced constipation, the ONS Guidelines panel recommends initial treatment with osmotic (e.g., polyethylene glycol [PEG], magnesium citrate) or stimulant (e.g., senna, bisacodyl) laxatives in addition to lifestyle education (Rogers et al., 2020).
ISSN:1092-1095
1538-067X
DOI:10.1188/20.CJON.685-688